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ABSTRACT 
We show that UVA irradiation (365 nm) of the Pt
IV
 complex trans,trans,trans-
[Pt
IV
Cl2(OH)2(dimethylamine)(isopropylamine)], 1, induces reduction to Pt
II
 
photoproducts. For the mixed amine Pt
II
 complex, trans-
[Pt
II
Cl2(isopropylamine)(methylamine)] (2), irradiation at 365 nm increases the rate and 
extent of hydrolysis, triggering the formation of diaqua species. Additionally, irradiation 
increases the extent of reaction of complex 2 with guanosine-5´-monophosphate (GMP) 
and affords mainly the bis-adduct, while reactions with adenosine-5´-monophosphate 
(AMP) and cytidine-5´-monophosphate (CMP) give rise only to mono-nucleotide adducts. 
Density Functional Theory calculations have been used to obtain insights into the 
electronic structure of complexes 1 and 2, and their photophysical and photochemical 
properties. UVA-irradiation can contribute to enhanced cytotoxic effects of diamine 
platinum drugs with trans geometry. 
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Graphical Abstract  
 
Irradiation at 365 nm induces activation of this trans-Pt
IV
 diamine dichlorido dihydroxido 
anticancer complex via reduction to reactive Pt
II
 species. Additionally, light promotes the 
second aquation of Pt
II
 dichlorido species and their interaction with guanosine 
monophosphate, leading mainly to bis-nucleotide adducts. 
 
Keywords: Photoactivation, trans-platinum diamine, platinum anticancer complexes, DNA 
bases, NMR. 
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1. Introduction 
In recent years there have been major advances in understanding the factors which 
control the binding of platinum anticancer drugs (such as cisplatin) to DNA and of the 
consequences of DNA binding, which ultimately lead to cell death [1, 2]. An important step 
in the activity of platinum anticancer complexes is activation through hydrolysis [3], which 
is often a necessary and rate-limiting step in their reactions with DNA and other 
biomolecules. Not only is there current interest in cis diam(m)ine platinum complexes, but 
also in trans diam(m)ine complexes which can also exhibit interesting activity [4-11], even 
though transplatin itself is inactive [12]. Our recent investigations of trans platinum 
complexes containing aliphatic amines, such as trans-[PtCl2(
15
N-ipa)(
15
N-ma)], trans-
[PtCl2(
15
N-dma)(
15
N-ma)] and trans-[PtCl2(
15
N-dma)(
15
N-ipa)] (ipa = isopropylamine, ma 
= methylamine, and dma = dimethylamine) by 2D [
1
H,
15
N] HMQC NMR spectroscopy 
suggest that the dichlorido (less reactive) species is the predominant form present in cancer 
cells under physiological conditions [13], despite the high cytotoxic activity exhibited by 
these complexes. 
Photodynamic therapy (PDT) has attracted considerable attention for the treatment of a 
variety of cancers. The photochemistry of the platinum complexes is of particular interest 
since light can induce a wide range of electronic transitions [14]. Photoactivable Pt
IV
-azide 
complexes represent a promising area for new drug development [15-17]. 
Photochemical studies on transplatin (trans-[Pt
II
Cl2(NH3)2]), cisplatin (cis-
[Pt
II
Cl2(NH3)2]) and cisplatin-like complexes have shown that irradiation can induce 
substitution of chlorido ligands by solvent H2O or DMSO [18-20]. UVA light promotes the 
loss of the second chlorido of transplatin and also promotes DNA binding and cytotoxicity 
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[21]. Here we investigate the possibility of using irradiation to activate the cytotoxic Pt
IV
 
mixed diamine trans complex trans-[Pt
IV
Cl2(OH)2(dimethylamine)(isopropylamine)], 1, 
and the Pt
II
 analogue, trans-[Pt
II
Cl2(isopropylamine)(methylamine)], 2 (Figure 1) through 
photoreduction [22, 23] and photosubstitution. We report the effect of irradiation on the 
aqueous behaviour of complexes 1 and 2. In addition, we have studied the influence of 
irradiation over time on reactions of complex 2 with the nucleotides guanosine-5´-
monophosphate (GMP), adenosine-5´-monophosphate (AMP), and cytidine-5´-
monophosphate (CMP) (Figure 1). The reactions have been monitored by NMR 
spectroscopy and the corresponding adducts in each case (Table 1) have been characterized 
by NMR and mass spectrometry. 
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2. Materials and Methods 
Trans,trans,trans-[PtCl2(OH)2(dma)(ipa)], 1, and trans-[PtCl2(ipa)(ma)], 2, were 
prepared using previously described procedures [24, 25]. Guanosine-5´-monophosphate 
(GMP), cytidine-5´-monophosphate (CMP) and 9-methyladenine (9MeA) were purchased 
from Sigma-Aldrich and adenosine-5´-monophosphate (AMP) from Acros Organic. 
 
2.1. Sample preparation 
Stock solutions of 2.5 mM platinum complex were prepared unless otherwise stated. 
Stock samples were diluted for MS and LC-MS as explained below. Reactions between 
platinum complexes and mononucleotides were performed at 1:2 molar ratios. The pH of 
the final solution in each experiment was adjusted in the range 6 7 with 0.1 M NaOH. All 
pH measurements were made at 298 K on a Martini MI150 pH meter equipped with a 
chloride-free semi-micro combination electrode (Thermo Fisher Scientific) calibrated with 
standard buffers (pH 4, 7 and 10, Aldrich). 
 
2.2. Nuclear magnetic resonance (NMR) Spectroscopy 
1D 
1
H and 2D [
1
H, 
13
C] HSQC NMR spectra were recorded on a 500 MHz Bruker 
spectrometer using 5 mm tubes at 310 K. Solutions were prepared in 100 mM NaClO4 and 
90% H2O / 10% D2O with a final concentration [Pt] = 2.5 mM for 
1
H and [
1
H,
13
C] HSQC, 
and 15 mM for 
195
Pt NMR. 
1
H, and 
195
Pt NMR chemical shifts were internally referenced 
to TSP via 1,4-dioxane (3.76 ppm), and externally to K2PtCl6 (0 ppm), respectively. Water 
signals were suppressed using presaturation or Shaka methods [26]. 
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2.3. Mass Spectrometry 
MS characterization studies were carried out on an HCT-plus Bruker ion trap mass 
spectrometer. The final concentration used in these samples was 15 μM [Pt]. 
EsquireControl 5.2 software was used to analyse the MS spectra. Isotope modelling of the 
MS peaks was performed for all the assignments. Pt 9MeA adducts were characterized by 
ESI-MS on an API Q-START Pulsari Q-TOF mass spectrometer in the positive ion mode 
diluting the samples 50% with methanol. The final concentration was 50 μM [Pt]. 
 
2.4. Liquid Chromatography-Mass Spectrometry. 
High performance liquid chromatography (HPLC) was carried out on an Agilent 
ChemStation 1100 Series instrument, with a DAD detector. Part of the outflow was routed 
to the Bruker HCT-plus ion trap MS. Hystar 3.0 software was used to analyse the LC-MS 
data. The final concentration used in the LC samples was 1 mM [Pt]. For all analytical 
separations, a RP C18 column (250 × 4.6 mm, 100 Å, 5 m, Hichrom) was used, eluting 
with 5 30% acetonitrile gradients over varying time intervals with 0.1% trifluoroacetic 
acid as an ion-pairing agent and with UV detection at 275 nm. 
 
2.5. Irradiation 
The light source was a Luzchem LZC-ICH2 illuminator (photoreactor) oven using both 
Luzchem LZCUVA (Hitachi) and LZC-VIS (Sylvania cool white) lamps, with no other 
sources of light filtration. The photoreactor operated at 365 nm ( max) with temperature 
controller at 310 K and power level of 1.9 mW/cm
2
. The power levels were monitored 
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using the appropriate probe window, calibrated with an OAI-306 UV power meter from 
Optical Associates, Inc.  
 
2.6. Computational Details 
All calculations were performed with the Gaussian 03 (G03) program [27] employing 
the DFT method and the PBE1PBE [28] functional. The LanL2DZ basis set [29]
 
and 
effective core potential were used for the Pt atom and the 6-31G**+ basis set [30] was used 
for all other atoms. Geometry optimizations of 1 and 2 in the ground state (S0) and lowest-
lying triplet state (T1) were performed in the gas phase and the nature of all stationary 
points was confirmed by normal mode analysis. For the T1 geometries the UKS method 
with the unrestricted PBE1PBE functional was employed. The conductor-like polarizable 
continuum model method (CPCM) [31] with water as solvent was used to calculate the 
electronic structure and the excited states of 1 and 2 in solution. Thirty-two singlet excited 
states with the corresponding oscillator strengths were determined with a Time-dependent 
Density Functional Theory (TD-DFT) [32, 33] calculation. The electronic distribution and 
the localization of the singlet excited states were visualized using the electron density 
difference maps (EDDMs) [34-36]. GaussSum 1.05 was used for EDDMs calculations and 
GaussSum 2.2 for the electronic spectrum simulation ( fwhm = 4000 cm
–1
) [37]. 
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3. Results and Discussion 
 
3.1. Irradiation of trans,trans,trans-[Pt
IV
Cl2(OH)2(dma)(ipa)] (1) in aqueous solution 
The thermal (dark, 310 K) and photo-induced (365 nm light) behaviour of complex 1 in 
water (2.5 mM, pH ca. 6) was monitored for 4 h using 
1
H NMR spectroscopy. 
Characterization of the products after 4 h was carried out by LC-MS and 
195
Pt NMR 
techniques. 
The 
1
H NMR spectrum of complex 1 in the dark over a period of 4 h (Figure 2A) 
showed no changes, indicating thermal stability. However, for the sample under irradiation 
(Figure 2B) several changes were observed. The doublet corresponding to the 
isopropylamine methyl groups (1.33 ppm) appears to split into two doublets, attributable to 
either isomerization and/or aquation of the Pt
IV
 complex as a result of the irradiation. Such 
effects have been documented previously for Pt
IV
 complexes containing halides and 
ammonia ligands, and have been used in synthesis [23, 38, 39]. Accordingly, it has been 
reported that irradiation of Pt
IV
 azide complexes gives rise to at least five additional Pt
IV
 
light-induced photoproducts [16].  Irradiation gave rise to new 
1
H resonances at 1.27 ppm 
corresponding to Pt
II
 species. This doublet is assignable to the methyl groups of the Pt
II 
counterpart [PtCl2(dma)(ipa)]. This doublet appears to be composed of two overlapping 
doublets, likely to be geometrical isomers cis and trans [23]. Additionally when the sample 
was irradiated, proton resonances for Pt
IV
NH and Pt
IV
NH2 groups (6.28 and 5.47 ppm, 
respectively) disappeared, and a new peak arose in the region of the Pt
II
NH2 signals 
(broad signal at 4.04 ppm, not shown) which provided evidence for photoreduction of 
complex 1. Several new peaks of low intensity were also observed in the high-field region 
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of the 
1
H NMR spectrum of the irradiated sample, which can be assigned to photo-
isomerisation and photo-substitution products formed upon irradiation. 
In order to identify the nature of the photoproducts, the samples were analyzed by LC-
MS. For the sample in the dark, elution produces only one peak at 7 min, and no 
differences were observed over 4 h (Figure S1A). However, when the sample was 
irradiated, the chromatogram showed two additional new peaks, eluting at 29 and 30 min 
(Figure S1B). The positive ion ESI-MS of the peak at 7 min showed a species at 426.96 m/z 
corresponding to {C5H18Cl2N2O2Pt + Na}
+
 assignable to complex 1 (Figure S2A). The 
ESI-MS data obtained for the two new peaks eluting at 29 and 30 min were alike (Figures 
S2B and S2C, respectively), showing a similar molecular ion at 376.07 and 376.02 m/z, 
respectively, both assignable to {C5H17ClN2Opt + Na}
+
, likely to be cis and trans isomers 
of reduced photoproducts of 1 [23]. 
The 
195
Pt NMR spectrum of a sample of 1 (15 mM, pH ca. 6) was recorded before and 
after the irradiation. The Pt
IV
 complex 1 was the only species present in solution before the 
irradiation ( (
195
Pt) +798 ppm). After irradiation a signal at 2185 ppm appeared in the 
spectrum (Figure S3). 
195
Pt NMR chemical shifts are highly dependent on the oxidation 
state of the metal, with Pt
II
 considerably more shielded than Pt
IV
 [40, 41]. The signal at 
2185 ppm corresponds to a Pt
II
 species, supporting the photoreduction reaction [42]. 
However, the 
195
Pt NMR spectrum failed to show any other Pt
II
 species, possibly because 
they do not accumulate in high enough concentration to be observed by 
195
Pt NMR 
spectroscopy. 
Comparison of the LC-MS and 
195
Pt NMR results obtained for Pt
IV
 and its Pt
II
 analogue 
indicates that 1 undergoes reduction under UVA light, in agreement with previous results 
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obtained by 
1
H NMR. The reduction mechanism of complex 1 in aqueous solution seems to 
be triggered, or at least promoted, by irradiation. 
 
3.2. Irradiation of trans-[Pt
II
Cl2(ipa)(ma)] (2) in aqueous solution 
We studied the effect of irradiation on the hydrolysis of 2, trans-[PtCl2(ipa)(ma)] by 
1
H 
NMR. Figure 3A shows the progress of hydrolysis of complex 2 in the dark. Two sets of 
1
H 
NMR signals at 1.27 and 1.31 ppm, assignable to isopropyl groups of the chloride (2) and 
monoaqua (2A) complexes, respectively. In the presence of light (Figure 3B), the same 
solution quickly gave rise also to a new set of peaks with a 
1
H NMR chemical shift of 1.35 
ppm, which is assignable to the diaqua species (2AA) [13]. Peaks corresponding to the 
diaqua species (2AA) are clearly dominant over the monoaqua species after 1.5 h 
irradiation (Figure 4). The diaqua species was detected only in the non-irradiated sample 
after 20 h [13]. 
Photolytic reactions of square-planar platinum(II) complexes in aqueous solutions 
include photoaquation and photoisomerizations [18, 20, 22]. For example, the 
photoaquation of cis- and trans-[Pt(NH3)2Cl2], with the concomitant release of chlorido 
ligands, has been previously reported and the quantum yield values for the photolysis 
reaction of both isomers determined [20]. Additionally, irradiation of trans-[Pt(NH3)2Cl2] 
induced further release of chloride in aqueous solution. The release of the second chloride 
from transplatin as a result of photoactivation may provide a mechanism for activation of 
the inactive trans complex [21].  
 
3.3. DFT and TD-DFT studies of photoactivation mechanisms for 1 and 2 
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DFT and TD-DFT calculations have been successfully employed to obtain insights in 
the mechanism of photoactivation of several metal complexes [43-46]. Characterization of 
singlet and triplet states (in the case of diamagnetic d
6
 metal complexes) can reveal 
fundamental information on such process. For this reason, the singlet ground state (S0) and 
the lowest-lying triplet state (T1) geometries were optimized for both 1 and 2 and thirty-two 
singlet states were calculated by TD-DFT from the S0 geometries of the two complexes to 
characterize their UV-Vis properties. A comparison between the calculated and 
experimental UV-Vis spectra of 1 and 2 is reported in the Supporting Information (Figures 
S4–S6 and Tables S1–S4), together with the orbital composition of selected singlet 
transitions. Interestingly, such calculations highlight that all the UV-Vis singlet transitions 
of 1 and 2 in the 210–500 nm range involve the LUMO orbital (Figure 5), which is *-
antibonding. The contribution of this orbital gives a strong dissociative character to such 
transitions, particularly towards the Pt–Cl bonds. This result is consistent with the 
labilization of the chlorido ligands upon light excitation. Furthermore, the lowest-lying 
triplet state (generally populated after the intersystem crossing promoted by the metal spin-
orbit coupling occurs) is dissociative as well. The highest-SOMO, in fact, corresponds to 
the LUMO of the ground state (shown in Figure 5), resulting in a dissociative state. The 
lowest-lying triplet geometry of 1 is distorted and has elongated Pt–Cl bonds, consistent 
with the dissociation of one of these ligands (Table 2). In the case of 2 the elongation of Pt–
Cl bonds upon triplet formation is limited, although there is a strong distortion of the Cl–
Pt–Cl angle. As shown previously in the case of other photoactive PtIV derivatives, the 
dissociation of one or more chlorido ligands and the subsequent formation of hydroxo-
species can lead to the reduction of the Pt centre via reductive photoelimination [47]. 
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3.4. Photoinduced reactivity of trans-[Pt
II
Cl2(ipa)(ma)] (2) with DNA model bases 
We studied the effect of irradiation on reactions of complex 2, trans-[PtCl2(ipa)(ma)], 
with the nucleotides: guanosine-5´-monophosphate (GMP), adenosine-5´-monophosphate 
(AMP) and cytidine-5´-monophosphate (CMP). 
 
3.4.1. Reactivity of trans-[PtCl2(ipa)(ma)] (2) with GMP 
The photoinduced reaction between complex 2 and two mol equivalents of GMP was 
monitored by 
1
H NMR by following the changes in the H8 peak of GMP (Figure 6), a 
resonance which is often useful for monitoring interactions of this nucleotide with metal 
complexes [48, 49]. The following GMP H8 peaks were assigned: 8.15 ppm, free 
nucleotide; 8.84 ppm for the mono-nucleotide adduct complex 3, trans-
[PtCl(GMP)(ipa)(ma)]
+
; and 8.97 ppm for the bis-adduct trans-[Pt(GMP)2(ipa)(ma)]
2+
 
complex 4. The intensity of the H8-4 signal (bis-adduct) in the photoinduced reaction was 
stronger than for the mono-nucleotide adduct after 4.5 h and also increased faster than for 
the non-irradiated sample (Figure 7). Monitoring the H8 chemical changes of the GMP 
ligand from the mono- and bis-nucleotide adducts versus pH suggests that the platination 
occurs at N7 of GMP since chemical shift changes associated with the pKa of the N7 were 
not observed, i.e. no changes in the H8 chemical shift of platinated GMP in the pH range 
2 4 (Figure S7) [50]. Similar results have been reported for complex 2 on reaction with 4 
mol equivalents of GMP (10 mM NaClO4, 310 K) under non-controlled lighting conditions 
[51]. 
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The presence of mono- and bis-GMP adducts was confirmed by MS. The mass 
spectrum of the non-irradiated sample (Figure S8A) showed the mono-nucleotide species: 
[PtCl(GMP)(ipa)(ma)]
+
 (3), assigned from the peak at m/z 684.12, {C14H28ClN7O8PPt}
+
, 
and the sodium adduct at m/z 706.09, {C14H27ClN7O8PPt + Na}
+
. Minor peaks were 
detected at m/z 665.16, {C14H29N7O9PPt}
+
, assignable to the hydrolysed mono-nucleotide 
adduct [Pt(H2O)(GMP)(ipa)(ma)]
2+
 (3A) and m/z 1010.23, {C24H41N12O16P2Pt}
+
, and 
(paired with  sodium ion) 1032.18, {C24H40N12O16P2Pt + Na}
+
, both assignable to the bis-
nucleotide adduct [Pt(GMP)2(ipa)(ma)]
2+
 (4). In the MS of the irradiated sample, the 
signals for the bis-nucleotide adduct were significantly more intense (Figure S8B), in 
agreement with the NMR results. The predominance of the bis-GMP adduct signals over 
the mono-nucleotide adduct has been reported for complex 2 [51] and other similar trans-
platinum(II) complexes, such as trans-[PtCl2(NH3)(c-C6H11NH2)] [52], under thermal 
conditions. However, in those cases, the reaction requires a significantly longer period of 
time (14 h for 2, and ca. 24 h for the latter) to achieve a similar percentage of speciation. 
The use of irradiation appears to activate and enhance the formation of the bis-nucleotide 
adduct 4. However, unlike the findings for transplatin, where the complex was totally 
consumed at the end of a 3 h-irradiation [21], most of complex 2 (ca. 75%) stays in the 
original dichlorido form. On the other hand, total conversion of transplatin into trans-
[Pt(NH3)2(GMP)2]
2+
 under non-irradiating conditions has been reported to occur within 
five hours at 308 K when the Pt/nucleotide ratio was 0.5 [48].  
 
3.4.2. Reactivity of trans-[PtCl2(ipa)(ma)] (2) with AMP 
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The effect of irradiation on the reaction of complex 2 with AMP was also investigated 
and monitored by NMR spectroscopy. The changes in the H8 and H2 
1
H NMR signals of 
AMP and its platinated adducts were followed over the first 4.5 hours. Two doublets were 
detected for both H8 and H2 with chemical shifts of 9.26 ppm (H8-5) and 9.15 ppm (H8-
5A) for H8, and 8.40 (H2-5) and 8.38 (H2-5A) for H2, in both non-irradiated and the 
irradiated samples (Figure 8). These signals in the 
1
H NMR spectra indicate the presence of 
two different AMP adducts. The 
1
H NMR signals of both adducts were of higher intensity 
after 4.5 h in the dark than under irradiation (Figure S9 shows the species distribution 
curves over 4.5 h).  
The Pt AMP adducts were characterized by MS. No bis-adducts were detected in the 
reaction of 2 with AMP. Two different species were assigned in the MS spectra to the 
following mono-nucleotide adducts: [PtCl(AMP)(ipa)(ma)]
+
 (5) to the peak at m/z 668.12 
({C14H28ClN7O7PPt}
+
), and peak at m/z 690.10, {C14H27ClN7O7PPt + Na}
+
 and 
[Pt(OH)(AMP)(ipa)(ma)]
+
 (5A) to the peak at m/z 649.16, {C14H29N7O8PPt}
+
 (Figure S10).  
In order to complete the assignment of the peaks observed by NMR, the magnitudes of 
chemical shift differences for H8C8 and H2C2 between the free base and the metallated 
base in the 2D [
1
H,
13
C] NMR spectra were analysed, since this appears to be a useful 
diagnostic tool [53, 54] for assignment of the type of binding in metal-nucleotide adducts. 
The shift changes for the 
13
C resonances were similar and small (up to ca. 3 ppm) for both 
mono-nucleotide adducts (Figure 9). The H8-adenine proton resonance, however, was low-
field-shifted by up to ca. 0.7 ppm compared to free AMP for both complexes 5 and 5A, 
while the H2 proton resonance was low-field-shifted by ca. 0.1 ppm compared to free AMP 
for both adducts. The greater shift changes in both species for proton H8 compared to H2 
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are attributed to N7 (as opposed to N1) AMP-Pt coordination [54]. A NOESY spectrum of 
the sample after 4 h of reaction of 2 and 5´-AMP showed cross-peaks only between the H8 
of the bound nucleotide and the isopropylamine and methylamine ligands in the platinum 
complex at 9.26 and 9.15 ppm, also suggesting coordination at N7. Interestingly, the two 
doublets, assigned to H8 in both mono-nucleotide adducts 5 and 5A 
([PtCl(AMP)(ipa)(ma)]
+
 at 9.26 and [Pt(OH)(AMP)(ipa)(ma)]
+
 at 9.15 ppm, respectively), 
coalescenced into one doublet upon lowering the pH with HClO4 (Figure S11). On 
increasing the pH to give basic solutions, however, the intensity of the H8-signal 
corresponding to one of the mono-nucleotide adducts decreased with concomitant increase 
in intensity of the H8-signal of the other mono-nucleotide adduct, hence the assignment of 
the former signal to 5, and the latter to 5A. Additionally, treatment of the solution mixture 
with 0.15 M NaCl resulted in an increase in the intensity of the peaks assigned to 5, 
although the anation was incomplete. Further addition of NaOH solution reversed the 
equilibrium towards 5A.  
LC-MS studies were carried out (mobile phase 0.1% TFA methanol/water, pH 2). Two 
different species were separated: AMP was detected as unreacted starting material at 
348.06 m/z, {C10H15N5O7P}
+
, and the mono-nucleotide adduct complex 5, 
[PtCl(AMP)(ipa)(ma)]
+
, at 668.09 m/z, {C14H28ClN7O7PPt}
+
. Under acidic conditions the 
only mono-nucleotide adduct present was complex 5, [PtCl(AMP)(ipa)(ma)]
+
.  
The assignation of species 5 and 5A was confirmed by an experiment carried out with 
another adenine derivative, 9-methyladenine (9MeA). When complex 2 was reacted with 
9MeA (Pt/nucleobase ratio 1:2, pH ca. 6.3, 24 h) three adducts were observed in the 
1
H 
NMR spectrum after just one hour (Figure S12). The ESI-MS recorded after 24 h showed 
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two peaks at m/z 451.15 ({C10H22N7OPt}
+
) and 470.12 ({C10H21ClN7Pt}
+
), assignable to 
trans-[Pt(OH)(9MeA)(ipa)(ma)]
+ 
and trans-[PtCl(9MeA)(ipa)(ma)]
+
, respectively. No bis-
nucleotide adducts were detected. Analysis of the 2D [
1
H,
13
C] HMQC NMR spectra 
allowed assignment of the three adducts as [PtCl(N7-9MeA)(ipa)(ma)]
+
 (6), 
[Pt(OH/OH2)(N7-9MeA)(ipa)(ma)]
+/2+
 (6A), and [PtCl(N1-9MeA)(ipa)(ma)]
+ 
(7) (Figure 
10). The assignment is based on the extent of shift of the 2D [
1
H,
13
C] H8C8 and H2C2 
signals of the platinated nucleobase when compared to those of the free nucleobase. N7-
coordination produced more pronounced low-field shifts (by up to ca. 0.8 ppm) of H8 in 
N7-metallated adenine, while as little as ca. 0.2 ppm for H2. Conversely, N1-coordination 
produced low-field shifts by up to ca. 0.6 ppm for H2 in N1-metallated adenine, versus 0.1 
ppm for H8. The ESI-MS under acidic conditions (0.5% TFA) showed only the mono-
chlorido/mono-9MeA adduct, [PtCl(9MeA)(ipa)(ma)]
+
, in agreement with the observations 
on the reaction of complex 2, trans-[PtCl2(ipa)(ma)], with AMP. 
Similarly, Liu et al. have reported an analogous behaviour for the thermal reaction of 
trans-[PtCl2(E-iminoether)2] with one mol equivalent of GMP or AMP. Trans-[PtCl2(E-
iminoether)2] appears to form two different mono-nucleotide adducts in aqueous solution at 
equilibrium (298 K), trans-[PtCl(E-iminoether)2(nucleotide)]
+
 and trans-[Pt(OH2)(E-
iminoether)2(nucleotide)]
2+
. The latter reversibly converts into the chlorido species at low 
pH and at high chloride concentration [55]. 
Interestingly, the proton resonances corresponding to H8 and H2 for the Pt AMP 
adducts show doublet splitting whilst the Pt GMP and Pt 9MeA complexes did not. This 
splitting effect may arise from hindered rotation about the Pt N bond [56-58]. However, 
temperature-dependent NMR experiments failed to show coalescence up to 323 K. In 
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agreement with the observations of this work, Marzilli et al. have observed greater steric 
effects in Pt
II
(AMP)2 adducts in comparison to Pt
II
(GMP)2 adducts, as confirmed by the 
coalescence temperature [57]. Additionally, Lippert et al. have previously observed an H2 
splitting phenomenon for trans-[Pt(MeNH2)2(1-MeT-N3)(9-MeA-N1)]
+
 in D2O. The 
authors attributed this to hindered rotation of the nucleobases about the Pt N bonds. Most 
importantly, it appears that hindered rotation depends on the presence of methylamine 
ligands bound to Pt since the NH3 analogue did not exhibit the same behaviour [59, 60]. 
 
3.4.3. Reactivity of trans-[PtCl2(ipa)(ma)] (2) with CMP 
Brabec and Leng showed that transplatin forms preferably GC interstrand crosslinks 
over GG adducts under competitive conditions [61]. The reaction of complex 2 with CMP 
in the dark and under irradiation at 365 nm was followed by 
1
H NMR spectroscopy and 
ESI-MS. The 
1
H NMR doublet corresponding to H6 of the cytidine mono-adducts was 
monitored over various irradiation times. Two new low-field-shifted doublets appeared and 
little difference was observed in the 1D 
1
H NMR spectra of irradiated samples in 
comparison to those kept in the dark (Figures S13 and S14). Accordingly, the ESI-MS data 
showed comparable spectra after 4 h reaction under irradiation and thermal conditions 
(Figure S15), with the main species being complex 8, [PtCl(CMP)(ipa)(ma)]
+
, as a 
molecular ion at m/z 644.10 {C13H28ClN5O8PPt}
+
 and m/z 666.07 {C13H27ClN5O8PPt + 
Na}
+
. No bis-adducts were detected by MS. When the NMR sample was acidified to pH 2 
only one Pt CMP adduct remained (Figure S16). Increasing the pH to 11 did not have an 
effect on the intensity of the signals. Due to the similarities between this reaction and the 
reaction of complex 2 with AMP, we tentatively assign the two new adducts as the mono-
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CMP/mono-chlorido adduct and mono-CMP/mono-aqua adduct, complexes 8 and 8A, 
respectively. Additionally, Figure S16B confirms CMP preferential binding to the metal 
centre through N3, which represents the more basic site (pKa  4.6) as compared to N4 (pKa 
17) [50]. 
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4. Conclusions 
Irradiation with UVA light (365 nm) of complex 1, trans,trans,trans-
[Pt
IV
Cl2(OH)2(dimethylamine)(isopropylamine)], in aqueous solution promotes reduction 
of platinum(IV) to platinum(II). When complex 2, trans-[PtCl2(ipa)(ma)], was irradiated in 
aqueous solution, the formation of bis-aqua species was facilitated. TD-DFT calculations 
suggested that all the UV-Vis singlet transitions of 1 and 2 in the 210–500 nm range 
involve the *-antibonding LUMO orbital, which has a strongly dissociative character 
(favouring Pt–Cl dissociation). The lowest-lying triplet state is dissociative as well. When 
an aqueous solution of 2 was irradiated in the presence of two mol equivalents GMP, 
formation of bis-adduct [Pt(GMP)2(ipa)(ma)]
2+
 was favoured; however, this was not the 
case for AMP nor CMP. When complex 2 reacted with AMP the mono-nucleotide adduct 
species [PtCl(AMP)(ipa)(ma)]
+
, 5, and [Pt(OH)(AMP)(ipa)(ma)]
+
, 5A, were detectable by 
NMR as the main Pt AMP adducts in solution. Interestingly, when 2 was reacted with 
phosphate- and sugar-free nucleobase derivative 9MeA, a new N1-bound species was 
found. When complex 2 reacted with CMP, only mono-nucleotide adducts 
[PtCl(CMP)(ipa)(ma)]
+
 (8) and [Pt(CMP)(ipa)(ma)(OH/OH2)]
+/2+
 (8A) could be observed 
and no bis-nucleotide adduct was detected. Our experiments suggest that irradiation at 365 
nm can be used to activate trans-Pt
IV
 di-amine complexes and aid the formation of bis-
nucleotide adducts with guanine derivatives, the preferred binding site for DNA-targeting 
platinum drugs. 
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Table 1. Numbering scheme for Pt
II
 adducts of general formula trans-[PtL1L2(ipa)(ma)]
n+
.
 
 
 
Complex Ligand 
L1 L2 
2 Cl Cl 
2A Cl H2O 
2AA H2O H2O 
3 GMP Cl 
3A GMP H2O 
4 GMP GMP 
5 AMP Cl 
5A AMP OH 
6 N7-9MeA Cl 
6A N7-9MeA OH/OH2 
7 N1-9MeA Cl 
8 CMP Cl 
8A CMP OH/OH2 
 
 
Table 2. Selected calculated bond distances (Å) and angles (deg) for complexes 1 and 2. 
 
 
Ground-State 
Geometry 
Lowest-Lying Triplet 
Geometry 
1 2 1 2 
Pt–N(ma) 2.093 2.056 2.125 2.122 
Pt–N(ipa) 2.062 2.056 2.114 2.111 
Pt–O 2.028 - 1.933 - 
Pt–O 2.021 - 1.932 - 
Pt–Cl 2.363 2.348 2.664 2.486 
Pt–Cl 2.357 2.350 2.645 2.487 
N–Pt–N 174.2 179.1 175.8 178.9 
O–Pt–O 177.3 - 176.7 - 
Cl–Pt–Cl 179.8 178.9 174.1 116.9 
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Figure captions. 
Figure 1. Structure of the platinum complexes and nucleotides studied in this work. 
Figure 2. High-field region of the 
1
H NMR spectra of complex 1, trans,trans,trans-
[Pt
IV
Cl2(OH)2(dimethylamine)(isopropylamine)], in aqueous solution over time: (A) in the 
dark, and (B) under irradiation. The doublet corresponds to the CH3-isopropylamine 
(above) and the broad signals (below) to the NH2 and NH groups. 
Figure 3. 
1
H NMR spectra of complex 2, trans-[PtCl2(ipa)(ma)] in aqueous solution over 
time at 310 K: (A) in the dark, and (B) under irradiation. Labels:  dichlorido (2),  
monoaqua (2A),  diaqua (2AA). 
Figure 4. Time dependence of the aquation of complex 1, trans-[PtCl2(ipa)(ma)]: (A) in 
the dark, (B) under irradiation. Labels: , dichlorido (2), , monoaqua (2A), , diaqua 
(2AA) and –, other species (i). 
Figure 5. Selected orbitals (isovalue 0.02) for complex 1 and 2 for the singlet ground-state 
optimized geometry. 
Figure 6. Progress of the reaction between complex 2 with GMP as monitored by 
1
H NMR 
spectroscopy, showing changes in the H8 region: (A) in the dark, (B) under irradiation. 
Labels: H8, GMP free; 3, [PtCl(GMP)(ipa)(ma)]
+
; and 4, [Pt(GMP)2(ipa)(ma)]
2+
. H8-GMP 
free chemical shift changes to higher field in the irradiated sample (B) indicates 
monophosphate group protonation (pKa 6.2) [ref. 50], since the pH of the sample shifted 
from 6.5 and 6.0 after the photoinduction reaction. 
Figure 7. Kinetic profiles of complex 2 reactivity with GMP, (A) in the dark and (B) under 
irradiation. Labels: , GMP free; , complex 3; , complex 4. The concentration of the 
bis-adduct complex 4 has been calculated taking into account the different stoichiometry. 
Figure 8. Progress of the reaction between 2 and AMP as monitored by 
1
H NMR (low 
field), (A) in the dark, (B) under irradiation. Labels: H8 and H2, AMP free; 5, 
[PtCl(AMP)(ipa)(ma)]
+
; 5A, [Pt(OH)(AMP)(ipa)(ma)]
+
. 
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Figure 9. 2D [
1
H, 
13
C] HMQC NMR spectra from the reaction of AMP with complex 2 
after 4.5 h, showing signals in the H8/C8 and H2/C2 regions. Labels: 5, 
[PtCl(AMP)(ipa)(ma)]
+
; 5A, [Pt(OH)AMP(ipa)(ma)]
+
; H8/C8 and H2/C2, AMP free. 
Figure 10. 2D [
1
H,
13
C] HMQC NMR after 4 h of the reaction of complex 2 with 9MeA. 
Labels: 6, trans-[PtCl(ipa)(ma)(N7-9MeA)]
+
; 6A, trans-[Pt(ipa)(ma)(N7-
9MeA)(OH/OH2)]
+/2+
; 7, trans-[PtCl(ipa)(ma)(N1-9MeA)]
+
; and H2/2 and H8/C8, 9MeA 
free. 
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Figure 4  
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Figure 5 
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